(Q26749132)

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27125562%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

F Cristini

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27125562%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

F G De Rosa

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27125562%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

S Esposito

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27125562%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

F Menichetti

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27125562%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

M Tumbarello

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27125562%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

M Venditti

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27125562%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

P Viale

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27125562%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

C Viscoli

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27125562%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

M Bassetti

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27125562%20AND%20SRC:MED&resulttype=core&format=json

Clinical Microbiology and Infection

4 June 2020

language of work or name

English

0 references

publication date

April 2016

0 references

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27125562%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

volume

22 Suppl 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27125562%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

page(s)

S27-36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27125562%20AND%20SRC:MED&resulttype=core&format=json

Complicated skin and soft tissue infection

4 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

Managing skin and soft-tissue infection and nosocomial pneumonia caused by MRSA: a 2014 follow-up survey

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

Epidemiology and microbiology of skin and soft tissue infections

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

Bacteriology of skin and soft-tissue infections: comparison of infections in intravenous drug users and individuals with no history of intravenous drug use.

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

Comparison of Staphylococcus aureus from skin and soft-tissue infections in US emergency department patients, 2004 and 2008

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

Methicillin-resistant Staphylococcus aureus in community-acquired skin infections

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

In vitro activity of ceftaroline and comparator antimicrobials against European and Middle East isolates from complicated skin and skin-structure infections collected in 2008-2009.

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

Early appropriate parenteral antimicrobial treatment of complicated skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

Antimicrobial resistance: Not community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)! A clinician's guide to community MRSA - its evolving antimicrobial resistance and implications for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

Acute bacterial skin infections: developments since the 2005 Infectious Diseases Society of America (IDSA) guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

Global distribution of Panton-Valentine leukocidin--positive methicillin-resistant Staphylococcus aureus, 2006

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

Methicillin-susceptible Staphylococcus aureus in skin and soft tissue infections, Northern Italy

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

New rules for clinical trials of patients with acute bacterial skin and skin-structure infections: do not let the perfect be the enemy of the good

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

A collaborative model for endpoint development for acute bacterial skin and skin structure infections and community-acquired bacterial pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

Inappropriate initial antibiotic treatment for complicated skin and soft tissue infections in hospitalized patients: incidence and associated factors

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

Acute bacterial skin and skin structure infections (ABSSSI): practice guidelines for management and care transitions in the emergency department and hospital

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)(a).

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

Prediction of failure in vancomycin-treated methicillin-resistant Staphylococcus aureus bloodstream infection: a clinically useful risk stratification tool

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

Skin and soft-tissue infections requiring hospitalization at an academic medical center: opportunities for antimicrobial stewardship

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

Recurrent bacteraemia: A 10-year regional population-based study of clinical and microbiological risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

Optimizing delivery of care for patients with MRSA infection: focus on transitions of care

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

Early discharge of infected patients through appropriate antibiotic use.

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

A new approach to treatment of resistant gram-positive infections: potential impact of targeted IV to oral switch on length of stay

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

Healthcare-acquired infections in rehabilitation units of the Lombardy Region, Italy.

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

Once-weekly dalbavancin versus daily conventional therapy for skin infection

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

Resource use in patients hospitalized with complicated skin and soft tissue infections in Europe and analysis of vulnerable groups: the REACH study.

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

Treatment options for skin and soft tissue infections caused by meticillin-resistant Staphylococcus aureus:oralvs.parenteral; home vs. hospital

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

Current concepts in antimicrobial therapy against select gram-positive organisms: methicillin-resistant Staphylococcus aureus, penicillin-resistant pneumococci, and vancomycin-resistant enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

Consensus document on controversial issues in the treatment of complicated skin and skin-structure infections

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

Optimizing antibiotic therapy of bacteremia and endocarditis due to staphylococci and enterococci: new insights and evidence from the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

New Gram-positive antibiotics: better than vancomycin?

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

European perspective and update on the management of complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

Initial treatment failure in patients with complicated skin and skin structure infections

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

Community-onset methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: impact of antimicrobial therapy on outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

Epidemiology and outcomes of complicated skin and soft tissue infections in hospitalized patients

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

Linezolid-resistant staphylococcal bacteraemia: A multicentre case-case-control study in Italy.

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

Treatment of complicated skin and soft-tissue infections caused by resistant bacteria: value of linezolid, tigecycline, daptomycin and vancomycin

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

Considerations for higher doses of daptomycin in critically ill patients with methicillin-resistant Staphylococcus aureus bacteremia.

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

Retrospective case-control analysis of patients with staphylococcal infections receiving daptomycin or glycopeptide therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

A Randomized Trial of Clindamycin Versus Trimethoprim-sulfamethoxazole for Uncomplicated Wound Infection

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

Weight-based antibiotic dosing in a real-world European study of complicated skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

Considerations of antibiotic therapy duration in community- and hospital-acquired bacterial infections

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

Diagnosis and management of skin and soft-tissue infections (SSTI): a literature review and consensus statement on behalf of the Italian Society of Infectious Diseases and International Society of Chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

Skin and soft tissue infections: the new surgical infection society guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

Guidelines (2008) for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

European Surveillance of Antimicrobial Consumption (ESAC): outpatient parenteral antibiotic treatment in Europe

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

Comparative efficacy of antibiotics for the treatment of acute bacterial skin and skin structure infections (ABSSSI): a systematic review and network meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

Intravenous and oral antibiotics in respiratory tract infection: an international observational study of hospital practice

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

Efficacy and safety of linezolid versus vancomycin for the treatment of complicated skin and soft-tissue infections proven to be caused by methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

Impact of methicillin-resistant Staphylococcus aureus infections on key health economic outcomes: does reducing the length of hospital stay matter?

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

Comparison of vancomycin and linezolid in patients with peripheral vascular disease and/or diabetes in an observational European study of complicated skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

Tedizolid phosphate vs linezolid for treatment of acute bacterial skin and skin structure infections: the ESTABLISH-1 randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

Once-weekly dalbavancin versus standard-of-care antimicrobial regimens for treatment of skin and soft-tissue infections

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

How complicated skin and soft tissue infections are treated in Italy: economic evaluation of inpatient intravenous antibiotic treatment in seven hospitals

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

Hospitalist perspective on the treatment of skin and soft tissue infections

1 reference

https://api.crossref.org/works/10.1016%2FS1198-743X%2816%2930095-7

7 January 2021

10.1016/S1198-743X(16)30095-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27125562%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

1 reference